#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Aplastic anaemia Cutaneous T-cell lymphoma stage II Familial haemophagocytic lymphohistiocytosis Nephropathy Fibrodysplasia ossificans progressiva Osteopetrosis Lupus nephritis Desmoplastic small round cell tumour Anaplastic thyroid cancer Hairy cell leukaemia recurrent Juvenile idiopathic arthritis Intracranial germ cell tumour Urea cycle disorder Anti-neutrophil cytoplasmic antibody positive vasculitis Breast cancer metastatic More trials…

    Learn about Rare Diseases

    Cholangitis sclerosing Lennox-Gastaut syndrome – Life with Disease Alternating hemiplegia of childhood – Trials in Disease Angiosarcoma recurrent – Trials in Disease Langerhans cell sarcoma – Life with Disease Fragile X syndrome – Life with Disease Acute respiratory distress syndrome – Treatment Hereditary neuropathic amyloidosis – Treatment Acquired haemophilia – Treatment Haemophilia – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Metoprolol Tartrate Pyrazinamide Gskvx000000008866 Danicopan Tinzaparin Sodium Erenumab LTI-03 Omp11 Leucine DAPIGLUTIDE Sitagliptin Foscarnet Sodium Hexahydrate Insulin Human (Rdna) Bi 3032950 Ziltivekimab Radiprodil Verapamil Fingolimod Hydrochloride Ixazomib Obicetrapib More therapies…

    Learn about Your Condition

    Neuroendocrine carcinoma Cachexia Chronic lymphocytic leukaemia Schizoaffective disorder Langerhans' cell histiocytosis Bladder cancer Supraventricular tachycardia Dermatitis atopic Fontan procedure Bone metabolism disorder Paraesthesia Thromboembolectomy Dry mouth Post cardiac arrest syndrome Hypotension More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Eye Diseases

  • Study of levofloxacin, ketorolac trometamol, and dexamethasone eye drops for preventing inflammation and infection after cataract surgery in adults

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cataract
    Investigated Drugs:
    • KETOROLAC TROMETAMOL
    • Levofloxacin Hemihydrate
    • Levofloxacin
    Greece Italy Poland Spain Sweden

  • Efficacy and safety of ABP 938 compared with aflibercept in participants with neovascular age‑related macular degeneration

    Recruiting

    3 1 1
    Investigated Diseases:
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • Aflibercept
    Czechia Hungary Latvia Lithuania Poland Slovakia +1

  • Randomized Study of Intravitreal mk-8748 Compared with Aflibercept in Patients with Neovascular Age‑Related Macular Degeneration

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Age-related macular degeneration
    Investigated Drugs:
    • Aflibercept
    Estonia Germany Latvia Poland Spain

  • Safety and Efficacy of Sodium Phenylbutyrate Eye Drops in Children with Myopia

    Recruiting

    2 1
    Investigated Drugs:
    • Sodium Phenylbutyrate
    Austria Ireland

  • AMG 732 in Patients With Thyroid Eye Disease Who Did Not Respond or Relapsed After Previous Treatment

    Recruiting

    2 1 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • AMG 732
    France Greece Italy Poland Spain

  • Cenegermin Eye Drops for Persistent Corneal Epithelial Defect in Patients with Persistent Corneal Epithelial Defect

    Recruiting

    3 1 1
    Investigated Drugs:
    • Cenegermin
    • Oxybuprocaine Hydrochloride
    • Tetracaine Hydrochloride
    Czechia France Germany Hungary Italy The Netherlands +2
1 2 3 … 38
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!